9,444
Total Claims
$792K
Drug Cost
601
Beneficiaries
$1,319
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-97%
Opioid rate vs peers
0.1% vs 3.8% avg
+12%
Cost per patient vs peers
$1,319 vs $1,174 avg
+15%
Brand preference vs peers
10.2% vs 8.9% avg
Opioid Prescribing
0.1%
Opioid Rate
12
Opioid Claims
$37
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
90% generic
Brand: 958 claims · $597K
Generic: 8,416 claims · $192K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 203 | $80K |
| Abacavir/Dolutegravir/Lamivudi | 15 | $53K |
| Empagliflozin | 30 | $47K |
| Apixaban | 33 | $44K |
| Omega-3 Acid Ethyl Esters | 348 | $27K |
| Dulaglutide | 24 | $25K |
| Icosapent Ethyl | 81 | $21K |
| Budesonide/Formoterol Fumarate | 46 | $18K |
| Sitagliptin Phosphate | 18 | $18K |
| Rivaroxaban | 15 | $18K |
| Linaclotide | 25 | $14K |
| Semaglutide | 11 | $13K |
| Lipase/Protease/Amylase | 11 | $11K |
| Ticagrelor | 19 | $10K |
| Atorvastatin Calcium | 809 | $8,479 |
Prescribing Profile
Patient Profile
72
Avg Age
54%
Female
1.76
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data